Neuralink, a company developing brain chip technology, has announced the successful implantation of their device in the first human subject, with the individual recovering well. Prior to this milestone, Neuralink had opened applications for volunteer testers, after receiving approval from the FDA. They specifically sought individuals with half a hemisphere of their brain missing, in order to test the device’s ability to control or communicate through thought. This target group represents the primary focus of this groundbreaking technology.
Elon Musk, the founder of Neuralink, named their first product “Telepathy.” He explained that the chip allows users to imagine Stephen Hawking, who was able to communicate through thought faster than typing. This is the ultimate goal of Neuralink: to enable efficient communication through the power of the mind.
Neuralink did not provide further details on their future plans following this testing phase, nor did they disclose the number of participants involved.
TLDR: Neuralink, a brain chip technology company founded by Elon Musk, has successfully implanted their device in a human subject and is now focusing on individuals with half a hemisphere of their brain missing. Their first product, “Telepathy,” aims to enable faster communication through thought. Future plans and the number of participants in the testing phase remain undisclosed. (163 words)
Leave a Comment